We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+28.57%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
-$202M
Cap. Flow
-$355M
Cap. Flow %
-35.04%
Top 10 Hldgs %
17.77%
Holding
972
New
385
Increased
62
Reduced
71
Closed
428

Top Buys

Rank Stock Value
1
AHCO icon
AdaptHealth
AHCO
+$14.9M
2
CLGX
Corelogic, Inc.
CLGX
+$14.2M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$13.5M
4
GDRX icon
GoodRx Holdings
GDRX
+$13.3M
5
SHC icon
Sotera Health
SHC
+$13.1M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$32.8M
2
CZR icon
Caesars Entertainment
CZR
+$22.3M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$20.7M
4
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
+$15.2M
5
BHP icon
BHP
BHP
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 32.37%
2 Technology 10.24%
3 Industrials 10.18%
4 Financials 8.13%
5 Consumer Discretionary 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PE
101
DELISTED
PARSLEY ENERGY INC
PE
$2.49M 0.25%
+173,466
New +$2.06M
SFT
102
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$2.48M 0.25%
30,000
+27,459
+1,081% +$2.54M
V icon
103
Visa
V
$677B
$2.44M 0.24%
11,165
+208
+2% +$42.6K
NARI
104
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.37M 0.23%
+27,000
New +$1.91M
BSX icon
105
Boston Scientific
BSX
$65.8B
$2.34M 0.23%
+65,000
New +$2.34M
MRVI icon
106
Maravai LifeSciences
MRVI
$997M
$2.32M 0.23%
+82,813
New +$2.31M
TARA icon
107
Protara Therapeutics
TARA
$226M
$2.32M 0.23%
95,000
-5,000
-5% -$108K
SAIA icon
108
Saia
SAIA
$11.3B
$2.28M 0.23%
+12,500
New +$2.05M
ALSN icon
109
Allison Transmission
ALSN
$10.1B
$2.26M 0.22%
+52,500
New +$2.11M
TRIL
110
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.22M 0.22%
+150,000
New +$2.16M
NVST icon
111
Envista
NVST
$4.28B
$2.19M 0.22%
+65,000
New +$1.88M
BFH icon
112
Bread Financial
BFH
$4.21B
$2.19M 0.22%
36,590
-1,227
-3% -$61.7K
OUT icon
113
Outfront Media
OUT
$5.64B
$2.19M 0.22%
113,472
+18,852
+20% +$319K
BBL
114
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$2.13M 0.21%
39,916
-50,400
-56% -$2.31M
IPOD.U
115
DELISTED
Social Capital Hedosophia Holdings Corp. IV Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
IPOD.U
$2.13M 0.21%
+141,965
New +$1.7M
ABBV icon
116
PUT
AbbVie
ABBV
$458B
$2.12M 0.21%
19,800
+15,800
+395% +$1.52M
ETN icon
117
PUT
Eaton
ETN
$157B
$2.12M 0.21%
+17,600
New +$1.99M
ADBE icon
118
CALL
Adobe
ADBE
$89.5B
$2.1M 0.21%
4,200
-800
-16% -$386K
EEM icon
119
iShares MSCI Emerging Markets ETF
EEM
$28B
$2.1M 0.21%
+40,537
New +$1.95M
NBP
120
NovaBridge Biosciences American Depositary Shares
NBP
$205M
$2.09M 0.21%
+44,411
New +$1.75M
GM icon
121
General Motors
GM
$74.7B
$2.09M 0.21%
+50,000
New +$1.94M
LIN icon
122
PUT
Linde
LIN
$237B
$2.08M 0.21%
+7,900
New +$1.94M
ARBGU
123
DELISTED
Aequi Acquisition Corp Unit
ARBGU
$2.06M 0.2%
+200,000
New +$2.01M
PXD
124
DELISTED
Pioneer Natural Resource Co.
PXD
$2.06M 0.2%
+17,955
New +$1.75M
BGC icon
125
BGC Group
BGC
$5.58B
$2.05M 0.2%
512,104
-136,500
-21% -$477K
3 4
5
6 7

Similar funds

AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
AAI
Aequim Alternative Investments Mill Valley, California $5.16B AUM 9.8% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Maven Securities's Q4 2020 Portfolio in Review

As of Q4 2020, Maven Securities held 972 positions worth $1.01B, down 17% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Maven Securities withdrew a net $355M in Q4 2020, closing 428 positions and reducing 71 holdings. Its most notable exit was Immunomedics Inc, an estimated $32.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Maven Securities opened a new position in Corelogic, Inc. worth $14.7M.

  • Maven Securities's largest Q4 2020 buy was Corelogic, Inc.: 189,483 shares worth $14.7M.
  • Maven Securities added most to AdaptHealth in Q4 2020, an estimated $14.9M increase.
  • Maven Securities's biggest Q4 2020 reduction was Triterras, Inc. Class A Ordinary Shares, cutting an estimated $15.2M.
  • Maven Securities fully exited Immunomedics Inc in Q4 2020, selling an estimated $32.8M.
  • Maven Securities's ten largest holdings make up 18% of its $1.01B portfolio in Q4 2020.
  • Maven Securities opened 385 new positions and closed 428 in Q4 2020.
  • Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.01B.

Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.